Crown Castle to Present at the Morgan Stanley 2016 Technology, Media & Telecom Conference
Feb 17, 2016 21:15 pm UTC| Business
HOUSTON, Feb. 17, 2016 -- Crown Castle International Corp. (NYSE:CCI) ("Crown Castle") announced today that Jay Brown, Crown Castle’s Chief Financial Officer, is scheduled to present on Tuesday, March 1, 2016 at 4:50...
SteadyMed to Present at RBC Capital Markets 2016 Global Healthcare Conference
Feb 17, 2016 21:15 pm UTC| Business
SAN RAMON, Calif., Feb. 17, 2016 -- SteadyMed Ltd. (Nasdaq:STDY), a pre-NDA stage specialty pharmaceutical company focused on the development of drug products to treat orphan and high-value diseases with unmet...
Aegerion Pharmaceuticals to Announce Fourth Quarter 2015 Financial Results on Thursday, February 25
Feb 17, 2016 21:15 pm UTC| Business
CAMBRIDGE, Mass., Feb. 17, 2016 -- Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare...
Seneca Foods Completes the Acquisition of Diana Fruit Company
Feb 17, 2016 21:15 pm UTC| Business
MARION, N.Y. and SANTA CLARA, Calif., Feb. 17, 2016 -- Seneca Foods Corporation (“Seneca”) (NASDAQ:SENEA) (NASDAQ:SENEB) and Diana Fruit Co., Inc. (“Diana”) announced today that Seneca’s subsidiary, Gray Company, has...
Feb 17, 2016 21:10 pm UTC| Business
NEW YORK, Feb. 17, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Primero Mining Corp. (“Primero” or the “Company”) (NYSE:PPP) and certain of its officers. The class action, filed in...
Papa Murphy’s Holdings, Inc. to Announce Fourth Quarter and Full Year 2015 Results on March 9, 2016
Feb 17, 2016 21:05 pm UTC| Business
VANCOUVER, Wash., Feb. 17, 2016 -- Papa Murphy’s Holdings, Inc. (“Papa Murphy’s”) (NASDAQ:FRSH) today announced that it will host a conference call to discuss its fourth quarter and full year 2015 financial results on...
Feb 17, 2016 21:05 pm UTC| Business
NEWARK, Calif., Feb. 17, 2016 -- Revance Therapeutics, Inc. (NASDAQ:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for use in aesthetic and therapeutic indications, announced today that...
How the US–India tariff truce boosts major Indian industries, Surat to Pharma